Dimercaptopropanol (BAL) has excellent performance and dimercaprol injection is its end product.

Dimercaptopropanol (BAL), also known as 2,3-dimercaptopropanol and 2,3-dimercapto-1-propanol, has the chemical formula C3H8OS2 and is an organic compound. Dimercaprol appears as a colorless oily liquid with a smell similar to garlic. It is soluble in water, benzyl benzoate, methanol, ethanol, etc., but insoluble in fatty oils. Dimercaprol has pharmacological effects and has broad application prospects in the medical field.

Dimercaprol is a mercapto compound. In recent years, with the advancement of technology and the growth of market demand, the development speed of my country’s thiol compound industry has been accelerating, and local companies have gradually gained competitive advantages in the global market. Take Yangfan New Materials as an example. According to its semi-annual report, in the first half of 2023, the company’s thiol compounds and derivatives business achieved revenue of 300 million yuan. Benefiting from the increasing prosperity of the mercapto compound industry, my country’s dimercaprol market space is expected to further expand.

According to the “2023-2027 China Dimercaptopropanol (BAL) Market Monitoring and Future Development Prospects Research Report》shows that dimercaprol has excellent comprehensive properties and a wide range of applications. Dimercaprol has a high affinity with metal ions and can be used as a metal ion chelating agent, metal ion masking agent, etc. In addition, dimercaprol also has antioxidant, anti-inflammatory, detoxification, prevention and treatment of cardiovascular diseases, etc., and has broad application prospects in the medical field. In the future, as research continues to deepen, the development speed of the dimercaprol industry will accelerate.

Dimercaprol injection is an end product of dimercaprol. Its indications include acute lead encephalopathy in children, gold poisoning, arsenic poisoning and mercury poisoning. Shanghai General Pharmaceutical Co., Ltd. and Yuanda Pharmaceutical (China) Co., Ltd. are the main manufacturers of dimercaprol injection in my country. Currently, the number of children suffering from lead poisoning worldwide reaches nearly 1 billion. With the improvement of medical standards, the prevalence of lead poisoning in children in my country has declined, but there is still a gap compared with overseas developed countries. Against this background, the growing market demand for dimercaprol injection will provide favorable conditions for the development of the dimercaprol industry.

In terms of market competition, the world’s major producers of dimercaprol include Germany’s Merck, Germany’s Evonik, and Britain’s Johnson Matthey, among others. There are many participants in my country’s dimercaprol market, but they are dominated by small and medium-sized enterprises, and the industry concentration is low. Wuhan Huaxiang Kejie Biotechnology Co., Ltd., Chengdu West Asia Chemical Co., Ltd., and Hubei Shineng Chemical Technology Co., Ltd. are the main manufacturers of dimercaprol in my country.

          Industry analysts said that dimercaprol, as an organic compound, is widely used in many fields. In recent years, benefiting from the growth in application demand, the development speed of my country’s dimercaprol industry has accelerated. Compared with overseas developed countries, my country’s dimercaprol industry started late, and the market lacks leading companies. It is expected that in the future, with technological advancement, the concentration of my country’s dimercaprol industry is expected to increase.